BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30322612)

  • 1. Design, synthesis, and biological evaluation of novel nitric oxide releasing dehydroandrographolide derivatives.
    Yan L; Dai YX; Gu GL; Pan MB; Wu SC; Cao Y; Huang WL
    Chin J Nat Med; 2018 Oct; 16(10):782-790. PubMed ID: 30322612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
    Bao N; Ou J; Xu M; Guan F; Shi W; Sun J; Chen L
    Eur J Med Chem; 2017 Sep; 137():88-95. PubMed ID: 28558333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
    Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological activity evaluation of novel scopoletin-NO donor derivatives against MCF-7 human breast cancer in vitro and in vivo.
    Yu N; Li N; Wang K; Deng Q; Lei Z; Sun J; Chen L
    Eur J Med Chem; 2021 Nov; 224():113701. PubMed ID: 34315044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide-donating derivatives of hederacolchiside A
    Fang Y; Wang R; He M; Huang H; Wang Q; Yang Z; Li Y; Yang S; Jin Y
    Bioorg Med Chem Lett; 2017 Jan; 27(1):98-101. PubMed ID: 27866816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Biological Activity, and Apoptotic Properties of NO-Donor/Enmein-Type ent-Kauranoid Hybrids.
    Li D; Hu X; Han T; Xu S; Zhou T; Wang Z; Cheng K; Li Z; Hua H; Xiao W; Xu J
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents.
    Zou ZH; Lan XB; Qian H; Huang WL; Li YM
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5934-8. PubMed ID: 21843940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies.
    Zang Y; Huang L; Chen X; Li C; Ma J; Chen X; Zhang D; Lai F
    Eur J Med Chem; 2022 Dec; 244():114832. PubMed ID: 36270090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide-releasing derivatives of brefeldin A as potent and highly selective anticancer agents.
    Tian K; Xu F; Gao X; Han T; Li J; Pan H; Zang L; Li D; Li Z; Uchita T; Gao M; Hua H
    Eur J Med Chem; 2017 Aug; 136():131-143. PubMed ID: 28494251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O
    Li Q; Zou P; Sun J; Chen L
    Eur J Med Chem; 2018 Jan; 143():732-744. PubMed ID: 29220794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel quinoline derivatives carrying nitrones/oximes nitric oxide donors: Design, synthesis, antiproliferative and caspase-3 activation activities.
    Abdelbaset MS; Abdel-Aziz M; Abuo-Rahma GEA; Abdelrahman MH; Ramadan M; Youssif BGM
    Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800270. PubMed ID: 30500087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of ATB-429 derivatives containing a nitric oxide-releasing moiety.
    Wang C; Xia G; Liu X; Zhang R; Chai Y; Zhang J; Li X; Yang Y; Wang J; Liu M
    Bioorg Med Chem Lett; 2016 May; 26(9):2355-9. PubMed ID: 26995527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy.
    Ren SZ; Wang ZC; Zhu D; Zhu XH; Shen FQ; Wu SY; Chen JJ; Xu C; Zhu HL
    Eur J Med Chem; 2018 Sep; 157():909-924. PubMed ID: 30149323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
    Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
    Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway.
    Chen J; Wang T; Xu S; Zhang P; Lin A; Wu L; Yao H; Xie W; Zhu Z; Xu J
    Eur J Med Chem; 2017 Jul; 135():414-423. PubMed ID: 28463784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation.
    Hu X; Bai Z; Qiao J; Li H; Xu S; Wang X; Xu Y; Xu J; Hua H; Li D
    Eur J Med Chem; 2019 Jun; 171():169-179. PubMed ID: 30921757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel nitric oxide-releasing spirolactone-type diterpenoid derivatives with in vitro synergistic anticancer activity as apoptosis inducer.
    Li D; Han T; Tian K; Tang S; Xu S; Hu X; Wang L; Li Z; Hua H; Xu J
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4191-6. PubMed ID: 27491707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
    Gao X; Li J; Wang M; Xu S; Liu W; Zang L; Li Z; Hua H; Xu J; Li D
    Eur J Med Chem; 2018 Feb; 146():588-598. PubMed ID: 29407983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol.
    Du C; Dong MH; Ren YJ; Jin L; Xu C
    J Asian Nat Prod Res; 2017 Sep; 19(9):890-902. PubMed ID: 27809606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxicity of some new eriocalyxin B derivatives.
    Zhao Y; Niu XM; Qian LP; Liu ZY; Zhao QS; Sun HD
    Eur J Med Chem; 2007 Apr; 42(4):494-502. PubMed ID: 17189663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.